Elsebeth Budolfsen
Keine laufenden Positionen mehr
Profil
Elsebeth Budolfsen served as the Chief Executive Officer of ALK-Abello A from 2000 to 2000.
She then worked as the Director of Ferrosan ApS from 2000 to 2012.
Budolfsen also served as a Director for Ørsted A, NsGene A, Fertin Pharma A, and Contura International A.
She was the Managing Director of T-cellic A in 2005.
In addition, she was a Director of Bionor Pharma ASA from 2010 to 2011 and Vice President of Christian Hansen Holding A.
Budolfsen graduated from the University of Copenhagen.
Ehemalige bekannte Positionen von Elsebeth Budolfsen
| Unternehmen | Position | Ende |
|---|---|---|
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Direktor/Vorstandsmitglied | - |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Direktor/Vorstandsmitglied | 25.07.2011 |
| T-cellic A/S | Corporate Officer/Principal | 01.01.2005 |
| ALK-ABELLÓ A/S | Präsident | 01.01.2000 |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Direktor/Vorstandsmitglied | - |
Ausbildung von Elsebeth Budolfsen
| University of Copenhagen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| ORSTED A/S | Utilities |
| Private Unternehmen | 7 |
|---|---|
| Christian Hansen Holding A/S | Consumer Non-Durables |
Ferrosan ApS
Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Health Technology |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Consumer Non-Durables |
Contura International A/S
 Contura International A/S Medical SpecialtiesHealth Technology Contura International A/S develops and markets soft tissue fillers to the healthcare industry. Its products include Bulkamid, a class leading urethral bulking agent for treatment of stress urinary incontinence; and Aquamid, an aesthetic injectable volumiser. The company was founded on March 1, 2000 and is headquartered in Søborg, Denmark. | Health Technology |
| T-cellic A/S | |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
